Case sharing of "Clinical Study on Specific Dietary Fiber Nutrition Intervention for Type 2 Diabetes Mellitus".
Patient Information
Name: Jiang Moumou
Gender: Female
Age: 50 years old
Home address: Qianchuan, Huangpi District, Wuhan City, Hubei Province
Hospital: Wuhan Huangpi District Hospital of Traditional Chinese Medicine
Description
In 2011, he was diagnosed with type 2 diabetes mellitus in Huangpi District Hospital of Traditional Chinese Medicine, and used a hypoglycemic drug: pioglitazone, once a day, 30mg/time. Insulin used: Yousling 30R, 14 units in the morning and 12 units in the evening.
On November 24, 2016, he participated in the "Clinical Study of Dietary Fiber Intervention for Type 2 Diabetes", and the patient currently has polyuria symptoms and no complications and comorbidities.
physical examination
1. Inspection time: November 24, 2016
2. Height: 157cm
3. Weight: 59kg
4、BMI：23.9
Nutritional interventions
Specific prebiotic dietary fiber fortification interventions
(1) Insist on using hypoglycemic drugs according to the doctor's instructions and monitor blood sugar in real time.
(2) Received specific prebiotic-type dietary fiber nutrition fortification intervention, which was implemented on January 10, 2017.
a. Provided by: Medical Nutrition Research Center, Tsinghua Strait Research Institute;
b. Dosage and method: Take 2 times a day, 10 grams each time, and take it with warm water before meals;
c. Take-period: 12 weeks.
(3) Ensure a balanced diet and adequate water intake every day.
Analysis of results
Comparison of biochemical index results
| Check the items | Day 0 | 1 month later | After 4 months |
| Glycosylated hemoglobin (%) | 8.2 | 8.1 | 6.5 |
| Fasting blood glucose (mmol/L) | 10.3 | 10.3 | 6.5 |
| 餐后2h血糖（mmol/L） | 15.3 | 21.9 | 8.8 |
| Total cholesterol (mmol/L) | 5.06 | 4.93 | 5.10 |
| Triglycerides (mmol/L) | 0.62 | 0.94 | 1.2 |
| 低密度脂蛋白（mmol/L） | 2.3 | 2.14 | 3.5 |
| 高密度脂蛋白（mmol/L） | 1.84 | 1.65 | 1.1 |
The patient's glycosylated hemoglobin, fasting blood glucose and 2-hour postprandial blood glucose were high during the enrollment examination, indicating that the patient's glycemic control was poor. After 3 months of specific prebiotic nutritional intervention, glycosylated hemoglobin has been controlled within the normal range, fasting blood glucose and 2h postprandial blood glucose have been controlled, and blood lipid tests are also within the normal range, so it is recommended that patients continue to take specific prebiotics to help patients better control blood sugar and blood lipids.
Clinical findings are as follows:
When you first enrolled
After a one-month observation period
After 3 months of taking specific prebiotics